Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status ≤ 70) and advanced non-small-cell lung cancer

Sofia Baka, L. Ashcroft, H. Anderson, M. Lind, P. Burt, R. Stout, I. Dowd, D. Smith, P. Lorigan, N. Thatcher

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status ≤ 70) and advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science